다른 암호화폐로 이동

NVSNovartis AG

빠른 링크

포지션 계산기

포지션 크기 (USD)레버리지

필요한 마진

$10.00

NVS이 움직일 경우 P&L

+1%+$10.00

+5%+$50.00

+10%+$100.00

{leverage}배 레버리지로 거래 시작

Novartis AG

NVS

$151.00

+0.00% (24h)

주식티어 C레버리지 1000x

주요 요점

마지막 업데이트:: 2026-07-06

•노바티스는 영국 기반의 마이릭스 바이오를 최대 15억 달러(선지급 + 마일스톤)에 인수하기로 합의했으며, 2026년 하반기 완료 예정인 확정 구속 계약입니다.
•이번 거래는 항체-약물 접합체(ADC)를 제약 산업의 가장 경쟁적인 혁신 전선으로 강화하는 NMTi-ADC 기술을 목표로 합니다.
•인수자(NVS)는 마일스톤 위험을 평가함에 따라 단기적인 매도 압력에 직면할 수 있으며, 이전 유사 거래에서도 초기 하락이 있었습니다.
•ADC 전문 바이오텍 동종업체들은 인수 가능성 향상과 가치 평가 배수 상승 압력으로 혜택을 받습니다.
•영국 바이오텍 엑시트는 영국의 정밀 종양 생태계를 입증하며, 런던 상장 생명 과학 기업 및 유럽 헬스케어 지수에 약간의 긍정적인 신호를 제공합니다.

가격 및 시장 구조

차트 로딩 중...

거래 체제 상태

레버리지

1000x

(CoinUnited.io 최대)

변동성

N/A

용어집

상장 주식과 CFD의 핵심 용어를 한 줄씩 —— 독자와 AI 답변 엔진 모두에게 모호하지 않은 페이지를 위해.

주식 CFD	주가를 대상으로 하는 차액결제거래 —— 가격 익스포저만 제공하며, 해당 주식의 소유권은 아닙니다.
시간외 거래	거래소 정규장 밖에서 이루어지는 장전 및 장후 거래.
베이시스 리스크	CFD 기준가격과 거래소 체결가격이 같은 방향으로 움직이지 않을 위험.
주가수익비율(PER)	주가수익비율 = 주가 ÷ 주당순이익. 널리 쓰이는 밸류에이션 지표입니다.
매출총이익률	매출총이익 ÷ 매출액. 제품 단위의 수익성을 나타냅니다.
주당순이익(EPS)	주당순이익 = 당기순이익 ÷ 희석 발행주식수.

Get Started with Novartis AG

Start trading Novartis AG on CoinUnited.io with industry-leading leverage and fees that drop to 0% at the top VIP tier.

Trade with Leverage

Trade NVS CFDs with up to 1000x leverage on CoinUnited.io.

Up to 1000x leverage
Fees down to 0%
Advanced risk management tools

Trade NVS Now

Explore Stocks

Browse the full stocks market on CoinUnited.io with 125+ instruments.

125+ stocks instruments
Real-time market data
Professional charting tools

Browse Stocks

Learn Stocks Trading

Read our in-depth research and analysis on stocks markets.

Expert market analysis
Technical analysis basics
Daily market insights

Read Our Research

How to Trade Novartis AG: Step-by-Step Guide

Learn how to trade Novartis AG (NVS) on CoinUnited.io with up to 1000x leverageand volume-tiered fees that reach 0% at the top VIP level. Follow this simple step-by-step guide to start CFD trading today.

Create Your CoinUnited.io Account

✓Quick and free registration
✓Email and password setup
✓Two-factor authentication for security

Verify Your Identity

Complete the KYC verification process to unlock full trading features and higher limits.

✓Upload government-issued ID
✓Proof of address document
✓Usually verified within minutes

Deposit Funds

Fund your account using one of the supported deposit methods.

Deposit Methods

•Cryptocurrency deposits (BTC, ETH, USDT)
•Bank transfer available
•No minimum deposit requirement

Find NVS in the Stocks Section

Navigate to the stocks market section and search for NVS. You can trade Novartis AG as a CFD with up to 1000x leverage.

✓Search for "NVS" in the trading platform
✓Select CFD trading mode
✓Review the current price and market data

Place Your Trade

Choose your position direction (long or short), set your leverage, and enter your position size to trade Novartis AG.

✓Long (buy) if you expect NVS to rise
✓Short (sell) if you expect NVS to fall
✓Set stop-loss and take-profit levels

Monitor & Manage Risk

Keep track of your open positions and manage risk with stop-loss orders and position sizing.

✓Monitor P&L in real-time
✓Adjust stop-loss as needed
✓Never risk more than you can afford to lose

Order Types

Market Order

Execute immediately at the current market price. Best for quick entries.

Limit Order

Set a specific price to enter. The order fills only when the market reaches your price.

Stop-Loss Order

Automatically close your position at a specified price to limit potential losses.

Important Tips

• Start with a small position to understand how leverage works
• Always set a stop-loss to protect your capital
• Higher leverage amplifies both gains and losses
• Never invest more than you can afford to lose

Novartis AG 거래 준비가 되셨나요?

최대 1000x 레버리지

NVS 거래 시작하기

심볼

NVS

시장

주식

섹터

General

CU 상품 코드

NVS

Similar Stocks Assets

Explore other stocks instruments in the same sector as Novartis AG. Compare performance and find trading opportunities.

D-Wave Quantum Inc.

$17.52

▼9.5%

Snap Inc.

$5.42

▼8.6%

ProShares UltraShort Silver

$24.60

▲8.5%

TTM Technologies, Inc.

$121.62

▲8.2%

Chewy, Inc.

$23.02

▼6.8%

View all General →

저자 소개

CoinUnited.io Research Team

This Novartis AG page is compiled by CoinUnited.io's research team: analysts covering listed equities and global markets, working from primary filings and named third-party data rather than opinion.

우리의 연구 방법론

Every figure is traced to a primary or named third-party source and dated: financial statements from the company’s SEC filings, institutional ownership from Form 13F, analyst targets from aggregated third-party coverage, and market data from the CoinUnited reference price. The Source Map on this page lists each one with its source and the date we last checked it.

Disclaimer: content is for informational and educational purposes only and is not personalized financial advice. A stock CFD carries significant risk and provides price exposure only, not equity ownership. Always conduct your own research and consult a qualified financial advisor.

면책 조항 및 참고 자료

중요 위험 고지

A CoinUnited stock CFD gives price exposure to Novartis AG only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.

Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.

투자 결정 전에 사용자는 스스로 조사하고 자격을 갖춘 금융 전문가와 상담해야 합니다. 이 플랫폼의 제작자 및 운영자는 제공된 정보를 신뢰함으로써 발생할 수 있는 금융 손실 또는 기타 손해에 대해 어떠한 책임도 지지 않습니다.

Leveraged trading is extremely risky and you may lose your entire deposit.

방법론 개요

Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.

Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
Market data: the CoinUnited reference price and daily closes
Institutional ownership: SEC Form 13F quarterly filings
Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
Peer multiples: third-party trailing-twelve-month ratios

CoinUnited does not publish a price forecast or target for Novartis AG.

최종 방법론 검토: